Actuate Therapeutics (ACTU) has filed for up to 2,777,778 share offering by selling stockholders.

Security pros say teams should prioritize these two bugs because they potentially affect a wide range of IoT-based products.

Elraglusib is a Class-LeadingGSK-3β Inhibitor with a Novel, Multimodal Mechanism of Action in Multiple Refractory Cancer Trials Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s ...

Actuate Therapeutics has won Food and Drug Administration orphan-drug designation for its lead investigational drug product in a group of rare cancerous tumors. Actuate on Wednesday said the ...

A significant part of their success can be attributed to their growing emphasis on private label brands, the adoption of generative AI in e-commerce, and a strong focus on customer loyalty.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Florida A&M football is hosting South Carolina State for a Week 1 non-conference game on Ken Riley Field at Bragg Memorial Stadium. FAMU, opening its home slate for the 2024 season, hasn’t lost ...

11, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of ...

There aren’t any labels for this repository quite yet.